Schumer/Waxman Call For Industry Groups To Condemn Generic Drug Payoffs
This article was originally published in The Pink Sheet Daily
Executive Summary
In letters to PhRMA and GPhA, legislators point to FTC report detailing industry settlements as a sign of growing anti-competitive activity.